Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glyocogen synthase kinase-3 activity. - Jin-Ho,C.; Jin,H.; Chang-Hwan,Y.; Ji-Hyun,K.; Choon-Soo,L.; Seock-Won,Y.; II-Young,O.; Carsten,S.; Toyoaki,M.; Young-Bae,P.; Kenneth,W.; Hyo-Soo,K. (J Biol Chem, 2004)